AzTrials
AzTrials

Apical PeriodontitisNCT03425383

Association of Endodontic Infection With Cardiovascular Disease.

An observational study of Apical Periodontitis, run by Postgraduate Institute of Dental Sciences Rohtak at 1 site in India.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Chronic inflammation plays a crucial role in the genesis of atherosclerosis and at the same time promotes acute cardiovascular events. Periodontal and pulpal inflammation are two major low grade chronic inflammatory infectious disease of oral cavity. Read more about this study

Who is it for?
Ages 20 to 40 years, men onlyHealthy volunteers can take part
Conditions the study is for
Apical Periodontitis
What is being tested?
FMD and c-IMT
How many people
120 participants
Where
1 siteIndia
Study dates
1 Nov 2016to 30 Mar 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 40 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Study population: Study subjects will be obtained from the pool of OPD patients in the Department of Conservative dentistry and Endodontics, PGIDS, Rohtak.

Who may be able to join

  • 20-40 years of Male.
  • Presence of apical periodontitis as assessed both clinically and radiographically (teeth with apical symptoms but without radiographic appearance of AP were not include).
  • Presence of at least 25 teeth.
  • Echocardiographic Left Ventricle Ejection Fraction (LVEF) value >55%.
  • Hepatic and renal function within normal limits (bilirubin<1.5mg/dl; creatine<2.0mg/dl).

Who cannot join

  • Presence of localized or diffuse periodontal disease.
  • Presence of non-endodontic lesion in Maxilla/ mandible.
  • Presence of cardiovascular risk factors(arterial hypertension, dyslipidemia, DM, obesity, smoking)
  • LV hypertrophy at echocardiography previous or current CVD.
  • Presence of chronic inflammatory conditions in other regions involving systemic health.
  • For women, use of anticonceptive hormones.
  • Systemic antibiotic treatment within the previous 3 months or any other regular medication.

Trial locations and contacts

1 site in 1 country.

NISHANT CHAUHAN contact

9991772647

catchnishu619@gmail.com

India1 site, 1 recruiting
  • Post Graduate Institute of Dental Sciences

    Rohtak, Haryana, 124001

    Sanjay Tewari, 283876 ext. 01262, principalpgids@yahoo.in

    Recruiting

Other trials in India

About this study

Official title: Association of Endodontic Infection With Cardiovascular Disease Via Non-invasive Assessment of Endothelial Function

Chronic inflammation plays a crucial role in the genesis of atherosclerosis and at the same time promotes acute cardiovascular events. Periodontal and pulpal inflammation are two major low grade chronic inflammatory infectious disease of oral cavity. Apical periodontitis is an inflammatory process, most often chronic in nature, of endodontic origin usually occurring at or near apex of the tooth root. The scientific literature has failed to provide the potential connection between endodontic infection and CV risk. Few studies have found the possible association, yet few studies does not suggest any link. The association between chronic inflammatory lesions and endothelial dysfunction can be detected using inflammatory, invasive and non-invasive markers. Inflammatory markers such as hs-CRP and Interleukins are not cost efficient and invasive markers- Angiography and Plethysmography are unethical to use on asymptomatic subjects. Non-invasive markers such as Flow mediated dilatation (FMD) and carotid intima media thickness (c-IMT) are inexpensive, fast and safe. The rationale of our study is to check the possible association between endodontic infection and CVD using non-invasive markers.

Read the detailed description

Cardiovascular Disease (CVD) is the primary non-communicable cause of global mortality killing more than 7 million people per year. Chronic inflammation plays a crucial role in the genesis of atherosclerosis which further leads to cardiovascular disease. Apical periodontitis is "an acute or chronic inflammatory lesion around the apex of a tooth caused by bacterial infection of the pulp canal system". Histologically, it is represented by a periapical inflammatory response that arises after resorption of adjacent supporting bone and local infiltration of inflammatory cells. In response to chronic inflammation, endothelium dysfunction occurs which leads to switch from a Nitric Oxide environment to a reactive oxygen dominated (ROS)-dominated inflammatory environment. The nitric oxide environment of the normal functional endothelium helps to maintain an equilibrium in the circulating system by inhibiting platelet aggregation, monocyte adhesion and vascular smooth muscle cell proliferation. Coronary endothelial dysfunction is considered an early stage of atherosclerosis and is associated with an increased risk of ischaemic cardiovascular outcomes. Several cross-sectional and longitudinal studies has shown the association of Apical periodontitis and Cardiovascular disease. Yet some studies states that there is no correlation and some showing the result is inconclusive making this link very controversial. All the studies are either hospital record based studies or they used inflammatory biomarkers for evaluating the association between endodontic infection and CVD which are very expensive.

Clinically, vasoregulation has been measured in both the coronary and peripheral circulation, using changes in vessel diameter as an index of conduit vessel endothelial function. The three most common clinically used techniques are-(a) Angiography, (b) Flow mediated dilatation (FMD), (c) and Venous plethysmography. Due to the invasive nature of angiography and plethysmography, these methods are unsuitable to be used on asymptomatic patients.

On the other hand, the non-invasive nature of the FMD allows repeated measurements over time to study the effectiveness of various interventions that may affect vascular health. The sensitivity and specificity of FMD is 95% and 37% respectively. Impaired endothelium-dependent dilatation in the coronary circulation is associated with coronary atherosclerosis and coronary risk factors and improves with risk reduction therapies. It has been shown FMD was an independent predictor of cardiovascular disease. Thus, brachial artery flow-mediated dilation prove useful to assess cardio- vascular risk, guide therapy, and judge the potential utility of new interventions for cardiovascular disease. FMD, which is most widely used non-invasive ultrasound method to assess endothelial function has been used in various interventional and cross-sectional studies depicting the link between periodontitis and endothelial dysfunction. But no such studies has been done evaluating the link between endodontic infection and endothelial dysfunction using these markers.

Another commonly used non-invasive marker these days is Carotid Intima-media thickness (IMT). c-IMT is increasingly used as a surrogate end point of vascular outcomes in clinical trials aimed at determining the success of interventions that lower risk factors for atherosclerosis and associated diseases (stroke, myocardial infarction and peripheral artery diseases). This observer dependable technique, which serves both as an early detector and a follow up tool, provides information about common carotid (CCA), bifurcation, internal (ICA) and external carotid arteries. It has been established that abnormal baseline and rapid progressive CIMT are correlated to more cardiovascular and stroke events. Every 0.1 mm increase in the CIMT was associated with a 10-15% increase in the risk of myocardial infarction, and in the same line, a 13-18 % increase in stroke events. Many interventional and cross-sectional studies have shown the link between periodontitis and c-IMT.

No prospective observational trial, to the best of our knowledge, has been done till date depicting the link between endodontic infection and cardiovascular disease using FMD and c-IMT. The aim of the present study is to depict that endodontic infection is also one of the novel risk factor of CVD using a non-invasive techniques i.e. Flow mediated dilatation (FMD) and c-IMT.

AIMS AND OBJECTIVES To depict that Endodontic infection is associated with endothelial dysfuction by measuring flow mediated dilatation (FMD) of brachial artery and carotid intima media thickness (c-IMT) of common carotid artery.

MATERIALS AND METHODS

The present study will be done in the department of Radiology, PGIMS, Rohtak and Department of Cardiology, PGIMS, Rohtak.

Study subjects will be obtained from the pool of OPD patients in the Department of Conservative dentistry and Endodontics, PGIDS, Rohtak.

METHODOLOGY 35 patients who consecutively registered for a dental checkup at the OPD and fulfilled the previously mentioned criteria will be enrolled.

Additional 35 patients who were free from clinical and radiographic evidence of AP and met the inclusion and exclusion criteria of the study will be included as contols.

All individuals aged will underwent a complete CV assessment including medical history, physical examination, blood pressure measurement and 12-lead electrocardiogram.

A complete dental examination will be performed on each patient in both groups.

DENTAL EXAMINATION A panoramic radiograph will be examined and used as initial screening . It will be followed by selected periapical radiographs taken on teeth suspected of presenting AP and in all teeth with root canal treatments or presenting extensive restorations (including prosthetic restorations) with or without previous endodontic treatment.

Periapical radiographs were taken with a radiographic unit by using a long cone paralleling technique.

By using both radiographic and intraoral evaluations the following parameters were recorded:

  1. Number of teeth present
  2. Number and location of restored teeth
  3. Number of endodontically treated teeth
  4. Number and location of teeth affected by carious processes
  5. Soft tissue assessment (presence and location of swelling/sinus tracts)
  6. Periodontal probing
  7. Number and location of teeth with AP
  8. State of the upper and lower jaws Brachial Artery Assessment Patient preparation 1) Fast at least 8-12 hours before study. 2) Should not exercise, should not ingest substances like caffeine, high fat foods, vit C or tobacco at least 4-6 hours before study.

Clinical Procedure The diameter of the target artery (right brachial artery) was measured from two- dimensional ultrasound images, with a 70 MHz linear array transducer and a standard 128XP/10 system (Acuson, Mountain View, California, USA).

Patient is placed in supine position with arm comfortably placed. Right brachial artery will be imaged above antecubital fossa in longitudinal plane.

In each study 4 scans will be taken:

Scan1 (At rest) The subject lay at rest for at least 10 min before a first resting scan will be recorded.

Then diameter of the artery will be measured from anterior to the posterior "m" line (the interface between intima media and intima adventitia)

Arterial flow velocity will be measured, by means of a pulsed doppler signal at a 70deg angle to the vessel in the centre of the artery.

Scan 2 (Endothelium dependent FMD) Increased flow was then induced by inflation of a pneumatic tourniquet to a pressure of at least 50 mm Hg above systolic pressure for 4-5 min (reactive hyperaemia).

A second scan was taken for 30 s before and 90 s after cuff deflation, including a repeat flow velocity recording for the first 15 s after cuff release.

Brachial Artery diameter will be taken 45-60 sec after cuff deflation.

Scan3 (Again at rest) At least 10 min of rest is needed after reactive hyperaemia before another image is acquired to reflect the re-established baseline conditions.

Third scan is taken at this point of time. Scan4 (Endothelium independent FMD) Then 0.4 mg of nitroglycerine (GTN) is given sublingually. (GTN will be omitted if the patient refuse or if the patient had a history of migraine headaches, systolic blood pressure <100 mm Hg, previous adverse reaction to nitrates, or critical carotid artery stenosis) After 4 min fourth and final scan will be taken. Carotid intima-media thickness (c-IMT) Common carotid artery (CCA) will be used because of its convenience and high reproducibility.

c-IMT will be assessed by M-mode ultrasonography via a vivid 7 MHz linear array transducer and a standard 128XP/10 system (Acuson, Mountain View, California, USA) with participants in the supine position.

CCA will be scanned on longitudinal two-dimensional planes. Images will be obtained at the level of distal 1.0 cm of the right CCA. When an optimal image will be obtained, it was frozen on the R wave of the electro- cardiogram and stored on videotape.

For each segment, the c-IMT of the posterior wall will be measured automatically over 200 pixels with computer-assisted electronic callipers.

Maximal right CCA thickness will be measured and used for analysis. Primary Outcome variable The primary outcome variables observed for the study will be the difference in the FMD and c-IMT of the test group and control group.

Being tested
FMD and c-IMT
Keywords
Cardiovascular disease, FMD, c-IMT
Medical subject headings
Periapical Periodontitis, Cardiovascular Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • FMD and c-IMTDiagnostic test

    The diameter of the target artery (right brachial artery) will be measured from two- dimensional ultrasound images, with a 70 MHz linear array transducer and a standard 128XP/10 system (Acuson, Mountain View, California, USA).

    c-IMT will be assessed by M-mode ultrasonography via a vivid 7 MHz linear array transducer and a standard 128XP/10 system (Acuson, Mountain View, California, USA) with participants in the supine position.

Study groups in NCT03425383
Study groupRoleWhat they receive
Test groupSubjects having periapical disease diagnosed clinically and radiographically and free from any other systemic illness. FMD and c-IMT will be determined by ultrasound
Receives: Diagnostic Test: FMD and c-IMT
Control groupHealthy subject. FMD and c-IMT will be determined by ultrasound
Receives: Diagnostic Test: FMD and c-IMT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Difference in FMD and c-IMT between test and control groups.

    The primary outcome variables observed for the study will be the difference in the FMD and c-IMT of the test group and control group.

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Feb 2018
  2. Study start1 Nov 2016
  3. Primary completion30 Mar 2018 (estimated)
  4. Study completion30 Mar 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03425383
Sponsor's protocol ID
Nishant
Status last verified
Sep 2017
First submitted
31 Jan 2018
Last updated
7 Feb 2018
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Apical Periodontitis, run by Postgraduate Institute of Dental Sciences Rohtak at 1 site in India.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Feb 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in India. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact NISHANT CHAUHAN (9991772647, catchnishu619@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Difference in FMD and c-IMT between test and control groups. (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Feb 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in